On 19 September, the US Food and Drug Administration (FDA) chose to axe its ‘Final Rule’ from May 2024, bringing to an end a long-running agency-industry dispute around the proposed classification of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback